X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dasabuvir (249) 249
index medicus (172) 172
ribavirin (171) 171
humans (146) 146
abt-450/r-ombitasvir (127) 127
hepatitis c (120) 120
hepatitis c virus (120) 120
ombitasvir (110) 110
sofosbuvir (99) 99
hcv (96) 96
gastroenterology & hepatology (94) 94
hepatitis c, chronic - drug therapy (94) 94
antiviral agents - therapeutic use (90) 90
paritaprevir (89) 89
male (85) 85
ledipasvir (82) 82
female (78) 78
ritonavir (77) 77
antiviral agents (74) 74
drug therapy, combination (69) 69
hepatitis (69) 69
interferon (69) 69
cirrhosis (68) 68
hepacivirus - genetics (68) 68
middle aged (68) 68
genotype (67) 67
pharmacology & pharmacy (55) 55
sustained virological response (53) 53
aged (49) 49
antiviral agents - administration & dosage (49) 49
liver cirrhosis (49) 49
uracil - analogs & derivatives (48) 48
treatment outcome (46) 46
adult (45) 45
hepatitis c - drug therapy (43) 43
therapy (43) 43
virus-infection (43) 43
drug therapy (41) 41
hepacivirus - drug effects (41) 41
antiviral agents - adverse effects (40) 40
genotype 1 (38) 38
infectious diseases (37) 37
health aspects (36) 36
care and treatment (35) 35
genotype 1 infection (35) 35
infection (35) 35
liver (35) 35
direct-acting antivirals (34) 34
medicine, general & internal (34) 34
carbamates - therapeutic use (33) 33
infections (33) 33
macrocyclic compounds - therapeutic use (33) 33
anilides - therapeutic use (32) 32
sulfonamides - therapeutic use (32) 32
analysis (31) 31
daclatasvir (30) 30
simeprevir (30) 30
genotype & phenotype (29) 29
sustained virologic response (29) 29
hepatitis c, chronic - virology (28) 28
patients (28) 28
ribavirin - therapeutic use (28) 28
safety (28) 28
uracil - therapeutic use (28) 28
virology (28) 28
chronic hepatitis c (27) 27
macrocyclic compounds - administration & dosage (27) 27
anilides - administration & dosage (26) 26
carbamates - administration & dosage (26) 26
treatment-experienced patients (26) 26
gastroenterology and hepatology (25) 25
ritonavir - therapeutic use (25) 25
viruses (25) 25
microbiology (24) 24
ritonavir - administration & dosage (24) 24
abridged index medicus (23) 23
fibrosis (23) 23
sulfonamides - administration & dosage (23) 23
virus diseases (23) 23
genotypes (22) 22
combination (21) 21
hepatitis-c (21) 21
young adult (21) 21
genetic aspects (19) 19
hepatitis-c virus (19) 19
internal medicine (19) 19
telaprevir (19) 19
treatment-naive patients (19) 19
uracil - administration & dosage (19) 19
carbamates - adverse effects (18) 18
drug interactions (18) 18
hepatitis c, chronic - diagnosis (18) 18
medical research (18) 18
pegylated interferon (18) 18
protease inhibitors (18) 18
ribavirin - administration & dosage (18) 18
risk factors (18) 18
anilides - adverse effects (17) 17
dosage and administration (17) 17
hepatitis c - virology (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (255) 255
Hungarian (8) 8
German (5) 5
Korean (3) 3
Russian (3) 3
Czech (2) 2
French (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Liver International, ISSN 1478-3223, 01/2016, Volume 36, Issue S1, pp. 47 - 57
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 3, pp. 211 - 217
Background: The introduction of highly potent direct-acting combination therapies for HCV have negated the role of response-guided therapy and reduced the role... 
VIRAL LOAD | INFECTIOUS DISEASES | ABT-450/R-OMBITASVIR | ASSAY | VIROLOGY | RNA | DASABUVIR | MARKER | PERFORMANCE | PHARMACOLOGY & PHARMACY
Journal Article
World journal of gastroenterology, ISSN 1007-9327, 05/2019, Volume 25, Issue 18, pp. 2229 - 2239
The hepatitis C virus (HCV) NS5A inhibitor ABT-267 (ombitasvir, OBV), the HCV NS4/4A protease inhibitor ABT-450 (paritaprevir, PTV), the CYP3A inhibitor... 
Ombitasvir | Clinical Trials Study | Ritonavir | Genotype 1 | Paritaprevir | Hepatitis C | Dasabuvir
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9954, pp. 1597 - 1605
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
NATURE REVIEWS NEPHROLOGY, ISSN 1759-5061, 01/2016, Volume 12, Issue 1, pp. 5 - 6
Treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) can be challenging. Now, data from the phase III C-SURFER study... 
THERAPY | DIALYSIS PATIENTS | DASABUVIR | SAFETY | UROLOGY & NEPHROLOGY | HCV | RIBAVIRIN
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 7, pp. 1590 - 1598
Journal Article
United European Gastroenterology Journal, ISSN 2050-6406, 6/2019, Volume 7, Issue 5, pp. 699 - 708
Introduction Recent studies have suggested a higher recurrence rate of hepatocellular carcinoma (HCC) in patients with a history of HCC and hepatitis C virus... 
ombitasvir/paritaprevir/r+dasabuvir+ribavirin | Hepatitis C | direct antiviral therapy | hepatocellular carcinoma | liver cirrhosis | ombitasvir | r+dasabuvir+ribavirin | Original | paritaprevir
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 06/2015, Volume 60, Issue 12, pp. 1829 - 1836
Journal Article